PPARG and urinary bladder cancer: Unsupervised clustering of K5VP16;Pparg mutants and VP16;Ppargfl/fl control tumors using previously established immune gene signature demonstrated overall low levels of the immune response, similar to the UPPL luminal bladder cancer model (Fig. 4a,35).